Literature DB >> 9184980

Hemangioendothelioma of the temporal bone in a child.

R Eliashar1, D Saah, P Osin, J Y Sichel.   

Abstract

Hemangioendothelioma is a vascular tumor of endothelial cell origin. It may involve bone or soft tissues and can behave like a benign or a malignant tumor. In the literature there are several case reports on the involvement of the head and neck region, but only three cases of temporal bone involvement, all of them in adults. A 3-year-old child, complaining of left retro-auricular swelling and tenderness, was found to be suffering from hemangioendothelioma of the temporal bone. Doppler ultrasound and CT scan showed a highly vascular mass with bone destruction. Wide surgical excision was recommended, but rejected by the parents, nor did they agree to treatment with alpha-interferon. The child did not return for any further treatment.

Entities:  

Mesh:

Year:  1997        PMID: 9184980     DOI: 10.1016/s0165-5876(96)01480-2

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  4 in total

1.  Primary temporal bone angiosarcoma: a case report.

Authors:  Martin Scholsem; Daniel Raket; Pierre Flandroy; Raf Sciot; Manuel Deprez
Journal:  J Neurooncol       Date:  2005-11       Impact factor: 4.130

2.  Hemangioendothelioma of the temporal bone with radiologic findings resembling hemangioma.

Authors:  R A Ibarra; P Kesava; K K Hallet; C Bogaev
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

3.  High grade hemangioendothelioma of the temporal bone in a child: a case report.

Authors:  Hyo Lim Kim; Soo Ah Im; Gye Yeon Lim; Ho Jong Chun; Heejeong Lee; Hyun Jin Park; Jae Young Byun
Journal:  Korean J Radiol       Date:  2004 Jul-Sep       Impact factor: 3.500

Review 4.  Epithelioid hemangioendothelioma of the infundibular-hypothalamic region: case report and literature review.

Authors:  Abderrahmane Hamlat; Carlos Casallo-Quilliano; Stephan Saikali; Thierry Lesimple; Gilles Brassier
Journal:  J Neurooncol       Date:  2004-05       Impact factor: 4.130

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.